ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
News
August 6, 2024
22 Sep 2022

Helen Ljungdahl Round, President and CEO presents at Redeye event, Theme: Diagnostics

On September 27 at 9.00am CEST, Helen Ljungdahl Round, President and CEO at Acarix presented the company´s latest developments within d...
Continue reading
author-avatar acarix
News
August 6, 2024
06 Sep 2022

Highlights from the European Society of Cardiology Congress 2022

In the Special Session ‘Best of the European Heart Journal – Digital Health’ Simon Winther, MD, PhD, Gødstrup Hospital, Denmark was inv...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report
November 18, 2024
25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte...
Continue reading
author-avatar acarix
Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish
November 18, 2024
25 Aug 2022

Acarix AB (publ) publicerar delårsrapport, januari – juni 2022

Stort intresse och positiv utveckling på den amerikanska marknadenVi kan nu konstatera att vår Go-To-Market strategi i USA ...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Aug 2022

Acarix AB (publ) publicerar delårsrapport, januari – juni 2022

Stort intresse och positiv utveckling på den amerikanska marknaden Vi kan nu konstatera att vår Go-To-Market strategi i USA börjat gene...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US market We can now conclude that our Go-To-Market strategy in the USA has start...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Aug 2022

Invitation to presentation of Acarix´s second quarter report

Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Aug 2022

Inbjudan till presentation av Acarix delårsrapport för andra kvartalet

Acarix publicerar sin rapport för andra kvartalet torsdagen den 25 augusti 2022 kl 08.00. En direktsänd websändning hålls kl 14.00 (CES...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
22 Aug 2022

Invitation to presentation of Acarix´s second quarter report

Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
22 Aug 2022

Inbjudan till presentation av Acarix delårsrapport för andra kvartalet

Acarix publicerar sin rapport för andra kvartalet torsdagen den 25 augusti 2022 kl 08.00. En direktsänd websändning h&ar...
Continue reading
author-avatar acarix
News
August 6, 2024
04 Jul 2022

Samuel Schmidt, Co-founder at Acarix has received the Danish MedTech Society’s Rosenfalck Prize.

"At the Annelise Rosenfalck Celebration, I received the Danish MedTech Society’s Rosenfalck Prize for my innovations. Annelise Ros...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
22 Jun 2022

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska

Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®Syst...
Continue reading
  • «
  • ‹
  • 36
  • 37
  • 38
  • 39
  • 40
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.